Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of an Anti-TSLP Monoclonal Antibody in the Management of Chronic Bronchial Disease Induced by Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Stem Cells Transplantation Recipients

NCT07771855 is registered in ClinicalTrials.gov with Hopital Foch as lead sponsor.

NCT NCT07771855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07771855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of an Anti-TSLP Monoclonal Antibody in the Management of Chronic Bronchial Disease Induced by Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Stem Cells Transplantation Recipients
Lead sponsor
Hopital Foch
Phase
Phase 2
Overall status
Recruiting
Start date
June 24, 2026
Completion date
January 31, 2029
Enrollment
36 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

bronchial disease, bronchiolitis obliterans syndrome (bos), hsct